Journal of Vascular and Interventional Radiology最新文献

{"title":"Single-Center Experience of Portal Vein Recanalization and Transjugular Intrahepatic Shunt Placement in Patients with Portovisceral Thrombosis","authors":"Emily Knott BS ,&nbsp;Baljendra Kapoor MD ,&nbsp;Jirapa Chansangrat MD ,&nbsp;Sasan Partovi MD ,&nbsp;Gregory Owendoff BS ,&nbsp;Nancy Obuchowski PhD ,&nbsp;Masato Fujiki MD ,&nbsp;Abraham Levitin MD ,&nbsp;Sameer Gadani MD","doi":"10.1016/j.jvir.2025.05.005","DOIUrl":"10.1016/j.jvir.2025.05.005","url":null,"abstract":"<div><h3>Purpose</h3><div>To determine the technical and clinical success rates and outcomes of portal vein recanalization (PVR) and portal and visceral vein recanalization (PVVR) with transjugular intrahepatic portosystemic shunt (TIPS) placement for the management of portal vein thrombosis (PVT), including with thrombus extension into tributary visceral veins (PVVT).</div></div><div><h3>Materials and Methods</h3><div>This retrospective study included 43 consecutive patients who underwent PVR or PVVR-TIPS placement at a single medical center. Of the 43 patients, 38 (88.4%) had chronic thrombus, and 21 (48.9%) had Yerdel Grade III or IV PVVT. Indications for PVR/PVVR-TIPS included variceal bleeding, refractory ascites, and liver transplant or surgical candidacy for patients with partial or complete occlusion. Evaluated outcomes included technical and clinical success rates, adverse events, main PV and TIPS patency, and reintervention rates. Cox proportional hazards regression analysis was used to evaluate potential predictors of reocclusion and need for reintervention.</div></div><div><h3>Results</h3><div>The technical and clinical success rates were 97.7% and 92.7%, respectively. Seven patients (16.3%) had adverse events. Over a median follow-up of 10.7 months, Kaplan-Meier analysis demonstrated primary patency rates of 86%, 61%, and 46% at 1, 6, and 12 months, respectively. The primary-assisted patency rates were 94%, 87%, and 74% at 1, 6, and 12 months, respectively. Reinterventions were needed in 18 patients (41.9%). No significant predictors of reocclusion or need for reintervention were identified. Eight patients underwent successful liver transplant; 7 received an end-to-end PV anastomosis.</div></div><div><h3>Conclusions</h3><div>PVR/PVVR-TIPS placement is safe, technically feasible, and associated with durable clinical improvement with high patency rates in patients with PVT, including with extension into tributary visceral veins.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1313-1320"},"PeriodicalIF":2.6,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predischarge Ultrasound as a Tool for Early Detection of Hemorrhagic Events Following Percutaneous Liver Biopsy.","authors":"Rajesh Sasidharan, Shubham Suryavanshi, Akhil Baby","doi":"10.1016/j.jvir.2025.05.001","DOIUrl":"10.1016/j.jvir.2025.05.001","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of the Patient-Reported Outcome Measure for Vascular Malformation and Outcome Measures for Vascular Malformation Questionnaires: A Prospective Cohort Study","authors":"Anna J. Gong MD,&nbsp;Rebecca Choi MD,&nbsp;Natalie Y. Ring MD,&nbsp;Tushar Garg MD,&nbsp;Tej Mehta MD,&nbsp;Clifford R. Weiss MD","doi":"10.1016/j.jvir.2025.05.008","DOIUrl":"10.1016/j.jvir.2025.05.008","url":null,"abstract":"<div><div>The Patient-Reported Outcome Measure for Vascular Malformation (PROVAM) and the Outcome Measures for Vascular Malformation (OVAMA) are validated tools to assess health-related quality of life (HRQoL) in patients with vascular malformations (VMs). This prospective study compared PROVAM and OVAMA across 250 patient responses to evaluate measure comprehensiveness and patient preferences. Among respondents, 165 (66.0%) reported pain. Those with pain significantly favored the PROVAM questionnaire (58.4%), whereas those without pain preferred OVAMA (68.9%; χ²=11.93, <em>P</em>=&lt;0.001). Anatomical location also influenced preferences: patients with trunk or extremity VMs favored PROVAM (35%) or showed no preference (38.8%), whereas those with a head/neck VM favored OVAMA (45.9%; χ²=11.09, <em>P</em>=&lt;0.001). These findings suggest that patient characteristics, such as the presence of pain and VM location, influence PROM preference. PROVAM’s focus on functional impact aligns with the needs of patients experiencing pain, while OVAMA’s emphasis on physical symptoms and appearance may be more relevant to those without pain. Tailoring patient-reported outcome measure selection may improve HRQoL assessment and patient-centered care.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1347-1351.e6"},"PeriodicalIF":2.6,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rare Manifestation of Sjögren Disease: Multiple Complex Bilateral Pulmonary Arteriovenous Malformations Treated with Staged Embolization","authors":"Abdul Rehman Mustafa MBBS ,&nbsp;Arun Kamireddy MD ,&nbsp;David Gullotti MD ,&nbsp;Alan D. Roumm MD ,&nbsp;Pali Shah MD ,&nbsp;Clifford R. Weiss MD","doi":"10.1016/j.jvir.2025.05.004","DOIUrl":"10.1016/j.jvir.2025.05.004","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1356-1358"},"PeriodicalIF":2.6,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and Effectiveness of Sharp Recanalization for Thoracic Central Venous Occlusion: A Systematic Review and Pooled Analysis","authors":"Nader Ashraf MBBS ,&nbsp;Yazan Chaiah MBBS ,&nbsp;Tarek Ziad Arabi MBBS ,&nbsp;Ashwin Venkatakrishnan MBBS ,&nbsp;Divya Srinivasan MBBS ,&nbsp;Aishwarika Basu MBBS ,&nbsp;Gillian Xu MBBS ,&nbsp;Roberto Luigi Cazzato MD, PhD ,&nbsp;Tim Fotheringham MBBS ,&nbsp;Behnam Shaygi MD, MSc","doi":"10.1016/j.jvir.2025.05.007","DOIUrl":"10.1016/j.jvir.2025.05.007","url":null,"abstract":"<div><h3>Purpose</h3><div>To systematically review the literature on the effectiveness, safety, and long-term outcomes of sharp recanalization techniques for thoracic central venous occlusions (CVOs).</div></div><div><h3>Materials and Methods</h3><div>A search in Embase, Ovid MEDLINE, and Scopus databases, from inception until December 2023, was conducted using terms related to “recanalization” and “venous occlusion.” A total of 4,979 records were identified and evaluated against the inclusion criteria. Data on technical success, patency rates, adverse events, and procedural details were extracted and analyzed as a pooled cohort. Statistical heterogeneity between studies was assessed using Cochran Q and <em>I</em>² statistics.</div></div><div><h3>Results</h3><div>Twenty-eight studies with 521 patients were included. The most common indications for sharp recanalization included access for hemodialysis (n = 246, 47.2%) and symptomatic relief (n = 244, 46.8%). Occlusions were frequently located in the right brachiocephalic vein (25.9%). The most common instrument was some form of needle (20 studies, 71.4%), followed by stiff guide wires (8 studies, 81.6%). The pooled rates for various outcomes were 93.2% (95% CI, 90.7–95.0) for technical success, 65.1% (95% CI, 58.9–70.7) for primary patency rate, 90.9% (95% CI, 83.9–95.0) for secondary patency rate, and 15.9% (95% CI, 13.0–19.3) for adverse event rate. Most of the adverse events were mild (73.8%) with only 3 events categorized as life-threatening/disabling and 2 as fatal. Significant publication bias was found for technical success and adverse event rates, whereas no publication bias was found for primary patency rate.</div></div><div><h3>Conclusions</h3><div>Sharp recanalization techniques offer a valuable alternative for managing thoracic CVOs, especially when conventional endovascular approaches fail.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1254-1267.e5"},"PeriodicalIF":2.6,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transjugular Splenocaval Shunt Creation for the Treatment of Portal Vein Cavernous Transformation with Recurrent Variceal Hemorrhage","authors":"Jun Tie MD,&nbsp;Lei Liu MD,&nbsp;Xulong Yuan MM,&nbsp;Jing Niu BS,&nbsp;Jiao Xu BS,&nbsp;Yongquan Shi MD","doi":"10.1016/j.jvir.2025.05.002","DOIUrl":"10.1016/j.jvir.2025.05.002","url":null,"abstract":"<div><h3>Purpose</h3><div>To describe transjugular splenocaval shunt (TSCS) technique and evaluate its feasibility, safety, and effectiveness in patients with cavernous transformation of the portal vein (CTPV) and complete thrombosis of the superior mesenteric vein (SMV).</div></div><div><h3>Materials and Methods</h3><div>In this retrospective analysis, baseline data, procedural outcomes, adverse events, rebleeding episodes, stent patency, hepatic encephalopathy (HE), and survival were retrospectively analyzed in patients with CTPV and recurrent variceal hemorrhage who underwent TSCS.</div></div><div><h3>Results</h3><div>Eleven patients (median age, 52 years; range, 25–63 years) with CTPV, complete SMV thrombosis, and recurrent variceal hemorrhage were included. Technical success was achieved in all cases, with no procedural mortality. After TSCS, the median splenocaval pressure gradient decreased from 28 mm Hg (range, 23–34 mm Hg) to 7 mm Hg (range, 5–10 mm Hg). During a median follow-up of 22 months (range, 6–39 months), 1 patient experienced rebleeding due to stent stenosis, which resolved after revision. Another patient developed asymptomatic stenosis. One patient developed medically manageable HE, and 3 had transient hyperbilirubinemia. There were no deaths or permanent severe adverse events.</div></div><div><h3>Conclusions</h3><div>TSCS appears to be a feasible and safe therapeutic option for patients with CTPV and complete SMV thrombosis who are refractory to conventional treatments.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1330-1335"},"PeriodicalIF":2.6,"publicationDate":"2025-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144013258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effectiveness of Metanephrine-Based Compared with Cortisol-Based Measurements to Assess Selectivity and Lateralization of Adrenal Vein Sampling in Primary Aldosteronism: A Systematic Review","authors":"Ibrahim Mohammad Nadeem BHSc, MD ,&nbsp;Yusra Rahman ,&nbsp;Laiba Nadeem ,&nbsp;Thulasie Manokaran MD ,&nbsp;Rachel Gow MD ,&nbsp;Anna Mathew MD, MPH ,&nbsp;Oleg Mironov MD ,&nbsp;Syed Umair Mahmood MBChB","doi":"10.1016/j.jvir.2025.04.020","DOIUrl":"10.1016/j.jvir.2025.04.020","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the effectiveness of metanephrine-based compared with cortisol-based measurements in assessing successful adrenal vein (AV) cannulation to determine diagnostic AV sampling (AVS) procedures.</div></div><div><h3>Materials and Methods</h3><div>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, a literature search was conducted using 3 electronic medical databases—PubMed, Embase, and MEDLINE—from inception to the third week of December 2024. Studies that compared metanephrine-based with cortisol-based measurements in adult patients with biochemically established primary aldosteronism undergoing AVS were included. The Methodological Index for Non-Randomized Studies appraisal tool was used for quality assessment. Cohen κ statistic, proportion differences, 95% confidence intervals (CIs), and 2-tailed <em>P</em> values using Z-test for paired proportions were calculated, where applicable.</div></div><div><h3>Results</h3><div>Six studies evaluating a total of 531 patients were included. Metanephrine-based selectivity index (SI) demonstrated significantly higher successful cannulation rates than cortisol-based SI in unstimulated AVS procedures for almost all the comparisons (<em>P</em> &lt; .05), whereas no significant difference was found in stimulated procedures (<em>P</em> &gt; .05). There was excellent agreement between metanephrine-based and cortisol-based SI (κ = 0.876; 95% CI, 0.779–0.972; n = 117) and substantial agreement for lateralization index (LI) (κ = 0.773; 95% CI, 0.658–0.889; n = 115). In patients successfully treated with adrenalectomy, no significant difference was found between metanephrine-based and cortisol-based LIs in identifying dominant side (n = 28).</div></div><div><h3>Conclusions</h3><div>This study was limited by the quality of evidence and heterogeneity. Compared with cortisol-based SI, metanephrine-based SI significantly increased the proportion of diagnostic unstimulated AVS procedures, supporting the use of metanephrine-based measurements as a reliable alternative.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1268-1277.e3"},"PeriodicalIF":2.6,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144023767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dynamic Contrast-Enhanced MR Lymphangiography: Feasibility in a Middle-Income Country","authors":"Daniela Torres Gómez MD ,&nbsp;Carlos-Eduardo Guerrero-Chalela MD ,&nbsp;Julián Forero Melo MD ,&nbsp;Yoav Dori MD, PhD ,&nbsp;Gabriel Caviedes MD ,&nbsp;Laura Acosta Izquierdo MD","doi":"10.1016/j.jvir.2025.04.015","DOIUrl":"10.1016/j.jvir.2025.04.015","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1363-1365.e1"},"PeriodicalIF":2.6,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Effectiveness and Safety of Radiofrequency Ablation Combined with Percutaneous Osteoplasty in the Management of Pubic Skeletal Metastases","authors":"Yu He MD ,&nbsp;Xiaoli Zhu MD, PhD ,&nbsp;Chungen Wu MD, PhD ,&nbsp;Tao Wang MD ,&nbsp;Bicong Yan MD ,&nbsp;Jianbo Wang MD, PhD","doi":"10.1016/j.jvir.2025.04.017","DOIUrl":"10.1016/j.jvir.2025.04.017","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the effectiveness and safety of combining radiofrequency (RF) ablation and percutaneous osteoplasty (POP) to relieve pain, enhance mobility, and improve the quality of life for patients with malignant pubic metastases.</div></div><div><h3>Materials and Methods</h3><div>A retrospective analysis was conducted on 29 patients with pain caused by pubic metastases who were treated between January 2014 and April 2024. All patients received RF ablation followed by POP, guided by biplane digital subtraction angiography (DSA) and performed under local anesthesia. The primary outcomes focused on pain reduction assessed by the visual analog scale (VAS), whereas the secondary outcomes included functional improvement evaluated by the Musculoskeletal Tumor Society (MSTS) system and quality of life measured using the Quality of Life Questionnaire-Bone Metastases 22 (QLQ-BM22). Procedure-related adverse events (AEs), survival rates, and Kaplan-Meier analysis were also evaluated during the follow-up period.</div></div><div><h3>Results</h3><div>All procedures were successfully completed without severe AEs. Significant improvements in VAS, MSTS, and QLQ-BM22 scores were observed postprocedurally (<em>P</em> &lt; .001). Leakage of polymethylmethacrylate occurred in 9 cases (9/29, 31.0%); however, none required additional treatment. During the follow-up period, a total of 12 patients (12/29, 41.4%) died, with the median survival time of 48.0 months (SD ± 13.83).</div></div><div><h3>Conclusions</h3><div>The combination of RF ablation and POP is a feasible and effective treatment modality for pubic metastases, providing significant pain relief, improved limb function, and enhanced quality of life. This minimally invasive approach is a viable treatment option for patients with advanced cancer and has a low risk of AEs.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1304-1312"},"PeriodicalIF":2.6,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endovascular Exclusion of a Giant Hepatic Venous Aneurysm with a Balloon-Expandable Stent Graft","authors":"Yasunori Hamaguchi MD,&nbsp;Masayoshi Yamamoto MD,&nbsp;Takaki Hirano MD,&nbsp;Hiroshi Kondo MD, PhD","doi":"10.1016/j.jvir.2025.04.016","DOIUrl":"10.1016/j.jvir.2025.04.016","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 8","pages":"Pages 1360-1363.e1"},"PeriodicalIF":2.6,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}